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`    Experimental design
1.   Sample size
Describe how sample size was determined. We grew up strains from 8 yeast colonies for each version of eCitrine, representing 
8 independent integrations of the eCitrine reporter into a fixed locus.
2.   Data exclusions
Describe any data exclusions. qPCR: We measured mRNA levels in three biological replicates (independent 
integrations of the eCitrine reporter) for each version of eCitrine. One integrant of 
eCitrineMAX was excluded because the RNA pellet was aspirated during the 
experiment, leaving two biological replicates of that strain.  
Flow cytometry: Biological replicates of yeast strains were excluded for the 
following reasons, documented in our analysis scripts on GitHub: 
1. eCitrine333: we discovered a polymorphism in the donor plasmid and tested 
each integrant for the mutation. We discarded 4 of 8 integrants because they were 
not wildtype at that position. 
2. eCitrine000, eCitrine333, yECitrine: one integrant of each eCitrine variant was 
discarded because the FACS data did not pass pre-determined filters for number of 
cells or had bimodal fluorescence. 
3. eCitrine999: one integrant was discarded because genomic copy number qPCR 
gave results inconsistent with a single copy integration.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
All attempts at replication were successful.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
For neural network training, genes were randomly allocated into the training set 
(2/3) or test set (1/3).
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Blinding was not relevant to our study.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
All iXnos software, transcriptome files used for alignments, and a complete script 
to reproduce our entire analysis including figures are available at: https://
github.com/lareaulab/iXnos 
Linkers were trimmed from ribosome footprints with custom code as documented 
in the paper and on GitHub. 
Alignments were performed with bowtie v. 1.2.1.1 and RSEM v. 1.2.31. 
The neural network method, iXnos, was implemented in python and is fully 
documented in the paper and on GitHub. It relied on python packages Lasagne v. 
0.2.dev1 and Theano v. 0.9.0. 
Flow cytometry was analyzed with custom R scripts fully documented on GitHub. 
They incorporated bioconductor packages flowCore v. 1.40.3, flowStats v. 3.32.0, 
and flowViz v. 1.38.0. 
All methods used to create the figures, including statistics and qPCR analsysis, are 
included as R scripts on GitHub.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
All materials and strains are readily available. Yeast strains will be provided on 
request. Commercial sources: 
Direct-zol RNA MiniPrep kit (Zymo Research) 
CircLigase I and II (Epicentre) 
DyNAmo HS SYBR Green qPCR Kit (Thermo Scientific) 
GoTaq DNA polymerase (Promega) 
Turbo DNase I (Ambion) 
Protoscript II (NEB)
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
No antibodies were used.
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10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. S. cerevisiae strains were constructed from frozen stocks of BY4741 and BY4742 
obtained from Thermo Fisher.
b.  Describe the method of cell line authentication used. Mating type and marker genotype were authenticated by growth on selective 
plates.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Yeast are not susceptible to mycoplasma contamination.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
No animals were used.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
The study did not involve human research participants.
